• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
AXLA

AXLA

Axcella Health Inc.

NASDAQHealthcareBiotechnologyUS

USD4.58

+0.00 (+0.00%)

Company Profile

CEO

Craig R. Jalbert CIRA

IPO Date

2019-05-09

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$0.36

Prev. Close

$4.58

Day Low

$0.36

Day High

$4.58

52W Low

$0.36

52W High

$4.58

Market Cap

$0.01B

Volume

0.01M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

39.8%

Avg Negative

3.5%

Avg Neutral

56.6%

News Feed

Axcella Health's (AXLA) CEO Bill Hinshaw on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·7/31/2021·↓ negative

Axcella Announces Initiation of EMMPOWER℠ Phase 2 Clinical Trial of AXA1665

Business Wire·6/30/2021·↑ positive

AXLA Stock Price: Over 10% Increase Pre-Market Explanation

Pulse2·5/24/2021·↑ positive

Positive Clinical Data About Axcella's AXA1665 Candidate for Overt Hepatic Encephalopathy Highlighted in Oral Presentation at DDW 2021

Business Wire·5/24/2021·↑ positive

Axcella Health's (AXLA) CEO Bill Hinshaw on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/9/2021·↓ negative

Exclusive: Axcella Health Aims To Become The Standard Of Care

Benzinga·4/15/2021·↑ positive

Axcella Announces AXA1125's IND Clearance for the Treatment of NASH

Business Wire·4/13/2021·↑ positive

Axcella Health's (AXLA) CEO Bill Hinshaw on Q4 2020 Results - Earnings Call Transcript

Seeking Alpha·3/17/2021·↓ negative

Axcella Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

Business Wire·3/17/2021·↑ positive

Axcella Announces Alison D. Schecter, M.D.

Business Wire·3/3/2021·↑ positive